Navigation Links
Leading Clinical Technology Organization M2S Inc. Announces the Appointment of Jeffrey Yablon as Senior Vice President, Business Development
Date:4/15/2009

M2S Inc., a clinical technology organization providing image management services for biopharmaceutical and medical device clinical trials and clinical data registries, announced today that it has named Jeffrey Yablon as its new Senior Vice President, Business Development. In his new role at M2S, Mr. Yablon will be responsible for managing all M2S sales efforts and overseeing the marketing strategy of the rapidly expanding Clinical Trials Imaging, endovascular, and Clinical Data Registries services, in addition to the development and implementation of strategic partnerships.

(PRWEB) April 15, 2009 -- M2S Inc., a clinical technology organization providing image management services for biopharmaceutical and medical device clinical trials and clinical data registries, announced today that it has named Jeffrey Yablon as its new Senior Vice President, Business Development.

Mr. Yablon brings over 20 years of experience in the life sciences industry, including senior management roles in pharmaceuticals, drug safety, laboratory management, clinical research, medical imaging and clinical technology. Before joining M2S, Mr. Yablon held the position of Vice President, Sales and Marketing with Sciformix Corporation, a knowledge process outsourcing organization providing pharmacovigilance services to biopharmaceutical and biotech companies. Prior to that position, he held the position of Vice President of Global Business Development at Perceptive Informatics, the technology division of Parexel International. He was also Chief Operating Officer at ICON Laboratories, a division of ICON Plc. Mr. Yablon is a founder of several companies as well as a current instructor and course director at Stony Brook University, Center for Biotechnology in Stony Brook, NY. He began his career at TAP Pharmaceuticals and Abbott Laboratories, where he held various positions of increasing responsibility in sales and marketing. Mr Yablon received his MBA from the executive program at Fairleigh Dickinson University. In his new role at M2S, Mr. Yablon will be responsible for managing all M2S sales efforts and overseeing the marketing strategy of the rapidly expanding Clinical Trials Imaging, Endovascular, and Clinical Data Registries services, in addition to the development and implementation of strategic partnerships.

"Jeffrey has extensive experience and in-depth industry knowledge of the clinical research and informatics industry, and therefore will be a great asset to our organization," said M2S's CEO, Wes Chapman. "He is a well respected and established leader in the clinical trials community, and our clients will greatly benefit from his understanding of their drug and medical device challenges in the new economy. His leadership, combined with the M2S clinical expertise, highly efficient processes and advanced technologies, will continue to advance our market share in the clinical trials and patient data registries markets."

Mr. Yablon says, "I am excited to be part of a truly differentiated Clinical Technology Organization that is able to combine best-in-class technical infrastructure with superior clinical acumen that will directly impact cost, quality, and efficiency to benefit our clients. I look forward to playing a key role in the growth of M2S."

About M2S
M2S is a Clinical Technology Organization (CTO), providing high-quality, timely and cost-effective image data management services for clinical trial sponsors in the biopharmaceutical and medical device industries as well as clinical registry databases. For the past 10 years, M2S has managed, under protocol, over 150 million images from around the globe in all major therapeutic areas and in all DICOM modalities. For more information, visit www.m2s.com

###

Read the full story at http://www.prweb.com/releases/clinical/trials/prweb2324234.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Frost & Sullivan Recognizes CRi for Innovations Leading to Personalized Medicine
2. Western Governors University to Launch Nations First Competency-Based B.S. in Nursing Leading to RN Licensure
3. HealthEquity, a Leading Healthcare Account Administrator, Licenses Thomson Reuters Information Solutions to Help People Make Better Healthcare Decisions
4. Nobel Prize Winner Professor Muhammad Yunus Leading Delegation From Bangladesh to World Health Care Congress to Advance Affordable Health Care Innovations
5. Global Med Technologies(R), Inc. Licenses Its Leading European Blood and Laboratory Solutions to Homburg, Germany Clinic Blood Center
6. New head-to-head clinical studies reveal Reach Ultraclean toothbrush and floss deliver superior plaque removal compared to leading competitive products
7. The Nation's Leading Health Care Strategy Firm Launches Post-Merger Integration Practice
8. Versus Technology to Showcase Leading Enterprise Patient and Clinical Workflow Solutions at HIMSS 2009
9. Last step leading to blood cell formation elucidated
10. Leading Autism Care Provider Invites MPs to Meet Residents and Staff for World Autism Awareness Day
11. Streamline Health to Deliver Hosted Document Workflow Solution to Leading West Coast University-Affiliated Surgery Department
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Leading Clinical Technology Organization M2S Inc. Announces the Appointment of Jeffrey Yablon as Senior Vice President, Business Development
(Date:5/31/2016)... ... , ... Psoriasis: Targets and Therapy has published ... author Professor Luigi Naldi says “The review in Psoriasis: Targets and Therapy throws ... onset and the severity of psoriasis, and negatively influences the response to systemic ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... individuals’ genetic characteristics and the physical and behavioral worlds in which they ... In personalized medicine, diagnosing an individual’s disease depends on accurately assessing his ...
(Date:5/31/2016)... ... May 31, 2016 , ... More than 80 representatives of the ... and the Prevent Cancer Foundation held an event on National Hepatitis Testing Day outside ... of viral hepatitis, the leading cause of liver cancer. , Foundation leaders and the ...
(Date:5/31/2016)... ... May 31, 2016 , ... Splashtop Inc., the worldwide leader in high ... Co., the leading provider of secure mobile remote access solution for Japan enterprises. ... CACHATTO remote access solution. Splashtop for CACHATTO will be available as an ...
(Date:5/31/2016)... ... ... Twenty years ago it was revolutionary: enabling the people who hear distressing voices to ... this approach has proven transformative, both for people who hear voices and for the ... used around the world, but it still lags in the United States. , Now, ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... May 27, 2016 According to ... hypertension is driving ambulatory blood pressure monitoring system market ... and their ability to respond to different pressure rates, ... can lead to various cardiovascular disorders such as heart ... These diseases are growing in prevalence each year. WHO ...
(Date:5/27/2016)... 27, 2016 Kitov ... focused on late-stage drug development, today announced the ... of pivotal batches required for registration of KIT-302 ... This follows Kitov,s announcement in December ... met its primary efficacy endpoint. "We ...
(Date:5/27/2016)... The healthcare sector is large ... all falling under its umbrella.  A rather overlooked sector ... talked about, these healthcare companies are still trying to ... is by far the largest consumer of the healthcare ... ADMD), Nutranomics Inc. (OTC: NNRX), KollagenX Corp. (OTCQB: KGNX), ...
Breaking Medicine Technology: